2. Young KS. Internet addiction : The emergence of a new clinical disorder 1996;Paper presented at the 104th annual meeting of the American Psychological Association. Toronto, Canada.
3. Cloninger CR, Dragan M, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975–990.
4. Cloninger CR. In: Silk KR, editor. The genetics and psychobiology of the seven-factor model of personality. Biology of Personality Disorders 1998;Washington DC: American Psychiatry Press. 63–92.
7. Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000;126:325–341.
8. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor variants: association and linkage studies in impulsive-addictive-compulsive behavior. Pharmacogenetics 1995;5:121–141.
9. Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S. A genetic association for cigarrette smoking behavior. Health Psychol 1999;18:7–13.
10. Muramatsu T, Higuchi S, Murayama M, Matsushita S, Hayashida M. Associstion between alcoholism and the dopamine D4 receptor gene. J Med Genet 1996;33:113–115.
11. Ishikawa H, Ohtsuki T, Ishiguro H, Yamakawa-Kobayashi K, Endo K, Arinami T, et al. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol Biomarkers Prev 1999;8:831–833.
12. Ashwin AP, Wade HB, Margret H, Charles CT, Edward G, Kevin H, et al. Serotonin transporter polymorphism and measures of impulsivity, aggression, and sensation-seeking among African-American cocaine-dependent individuals. Psychiatry Research 2002;110:103–115.
13. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhi GR, Lachman HM. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abuses. Am J Med Genet 1997;74:439–442.
14. Jerzy S, Jolanta KM, Ryszard K, Michael S, Hans R, Catrin W, et al. Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence. Psychiatry Res 2002;111:229–233.
15. DeCaria CM, Begaz T, Hollander E. Serotonergic and noradrenergic function in pathological gambling. CNS Spectr 1998;3:38–47.
16. Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001;49:914–921.
17. Hollander E, Begaz T, DeCaria CM. Pharmacological approaches in the treatment of pathological gambling. CNS Spectr 1998;9:72–80.
18. Carrion VG. Naltrexone for the treatment of trichotillomania: a case report. J Clin Psychopharmacol 1995;15:444–445.